Lipid screening in an elderly population: Difficulty in interpretation and in detection of occult metabolic disease

Journal of Clinical Pathology

Volumn 49, Issue 4, 1996, Pages 278-283

  Winder, A F ^a   Jagger, C ^b   Garrick, D P ^c   Vallance, D T ^a   Butowski, P F ^a   Anderson, J ^c   Clarke, M ^c   Winder, Tony ^d  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c Department of Chemical Pathology ^*

^d ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Diabetes; Immunoglobulins; Lipid screening; Lipids; Lipoproteins; Old age; Secondary dyslipoproteinaemia; Thyroid function

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPID; THYROTROPIN; TRIACYLGLYCEROL;

AGED; AGING; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029881252     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.4.278     Document Type: Article

References (44)

1. Ettinger WH, Wahl PW, Kuller LH, Bush TL, Tracy RP, Manolio TA, et al. Lipoprotein lipids in older people. Results from the cardiovascular health study. Circulation 1992;86:858-69.
2. Benefante R, Reed D. Is elevated serum cholesterol a risk factor for coronary heart disease in the elderly? JAMA 1990;263:393-6.
3. Barrett-Connor E. Hypercholesterolaemia predicts early death from coronary heart disease in elderly men but not women: The Rancho Bernado Study. Ann Epidemiol 1992; 2:77-83.
4. Zimetbaum P, Frishman WH, Ooi WL, Derman MP, Aronson M, Gidez LI, et al. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study. Arterioscler Thromb 1992; 12:416-23.
5. Forett B, Tortrat D, Wolmark Y. Cholesterol as a risk factor for mortality in elderly women. Lancet 1989;336:868-70.
6. Garber AM, Littenberg B, Sox H, Wagner JL, Gluck M. Costs and health consequences of cholesterol screening for asymptmatic older Americans. Arch Intern Med 1991; 151:1089-95.
7. Hazzard WR. Dyslipoproteinaemia in the elderly. Should it be treated? Clin Geriatr Med 1992;8:89-102.
8. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987;28:613-28.
9. Ball MJ, Griffiths D, Thorogood M. Asymptomatic hypothyroidism and hypercholesterolaemia. J R Soc Med 1991;84:527-9.
10. Kihara S, Matsuzawa Y, Kubo M, Nozaki S, Funahashi T, Yamashita S, et al. Autoimmune hyperchylomicronaemia. N Engl J Med 1989;320:1255-9.
11. Glueck CJ, Levy RI, Glueck HI, Gralnick HR, Greten H, Fredrickson DS. Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance. Am J Med 1969;47:318-24.
12. Evans P, Pereira Gray D. Value of screening for secondary causes of hyperlipidaemia in general practice. BMJ 1994; 309:509-10.
13. Jagger C, Clarke M, Clarke S. Getting older - feeling younger: the changing health profile of the elderly. Int J Epidemiol 1991;20:234-8.
14. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
15. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, et al. CAMDEX a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-703.
16. Clarke M, Jagger C, Anderson J, Battcock T, Kelly F, Campbell Stern M. The prevalence of dementia in a total population: a comparison of two screening instruments. Age Ageing 1991;20:396-403.
17. Mann JI, Lewis B, Shepherd J, Winder AF, Fenster S, Rose L, et al. Blood lipids and other cardiovascular risk factors; their prevalence in Britain. BMJ 1988;296:1702-6.
18. Kervinen K, Savolainen MJ, Salokannel J, Hyninnen A, Heikkinen J, Ehnholm C, et al. Apolipoprotein E and B polymorphisms - longevity factors assessed in nonagenarians. Atherosclerosis 1994;105:89-95.
19. Berg K, Ro OC. Lp(a) lipoprotein and longevity. Ann Genet 1991;34:264-9.
20. Tunbridge WMG, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol 1977;7:495-508.
21. Pocock SJ, Seed PT. Cholesterol in elderly women. Lancet 1992;339:1426.
22. Thompson GR. Cholesterol and the plasma lipoproteins. Chapter 17. In: M Hodgkinson, ed. Clinical biochemistry of the elderly. Edinburgh: Churchill Livingstone, 1984: 296-311.
23. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham Study. JAMA 1987;257:2176-80.
24. Barrett-Connor E, Criqui MH, Witztum JL, Philippi T, Zettner A. Population-based study of glycosylated haemoglobin, lipids and lipoproteins in non diabetic adults. Arteriosclerosis 1987;7:66-70.
25. Aviram M, Luboshitsky RR, Brook J. Lipid and liproprotein pattern in thyroid dysfunction and the effect of therapy. Clin Biochem 1982;15:62-6.
26. Bogner U, Arntz H-R, Peters H, Schleusener H. Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified. Acta Endocrinol 1993;128:202-6.
27. Series JJ, Biggart EM, O'Reilly DS St J, Packard CJ, Shepherd J. Thyroid dysfunction and hypercholesterolaemia in the general population of Glasgow. Clin Chim Acta 1988;172:217-21.
28. O'Kane M, Neely RDG, Trimble ER, Nicholls DP. The incidence of asymptomatic hypothyroidism in new referrals to a hospital lipid clinic. Ann Clin Biochem 1991; 28:509-11.
29. Glueck CJ, Lang J, Tracy T, Speirs J. The common finding of covert hypothyroidism at initial clinical evaluation for hyperlipoproteinaemia. Clin Chim Acta 1991;201:113-22.
30. Florkowski CM, Cramb R, Hughes EA. The incidence of asymptomatic hypothyroidism in new referrals to a hospital lipid clinic. Ann Clin Biochem 1992;29:237-8.
31. Jackson R, Beaglehole R. Evidence-based management of dyslipidaemia. Lancet 1995;346:1440-1.
32. Haq IU, Jackson PR, Yeo WW, Ramsey LE. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet 1995;346: 1476-81.
33. Jacobs D, Blackburn H, Higgins M, Reed D, Hiroyasu I, McMillan G, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992;86: 1046-60.
34. Johnson WD, Brenowitz JB, Kayser KL. Factors influencing long-term (10-year to 15-year) survival after a successful coronary artery bypass operation. Ann Thorac Surg 1989; 48:19-25.
35. Horvath KA, DiSesa VJ, Peigh PS, Couper GS, Collins JJ, Conn LH. Favourable results of coronary bypass grafting in patients older than 75 years. J Thorac Cardiovasc Surg 1990;99:92-6.
36. Brown BG, Zhao X-Q, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into plaque regression and clinical events in coronary disease. Circulation 1993; 87:1781-91.
37. Cosgrove DM, Loop F, Lytle BW, Gill CC, Golding LAR, Gibson C, et al. Determinants of 10-year survival after primary myocardial revascularisation. Ann Surg 1985;202: 480-90.
38. Scandinavian Simvastatin Survival Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study. Lancet 1994;344:1383-9.
39. Shepherd J, Cobbe S, Ford I, Isles G, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with Pravastatin in men with hypercholesterolaemia. N Engl J Med 1995;333:1301-7.
40. La Rosa JC, Applegate W, Crouse JR III, Hunninghake DB, Grimm R, Knapp R, et al. Cholesterol lowering in the elderly. Results of the cholesterol reduction in seniors program. Arch Intern Med 1994;154:529-39.
41. Kario K, Matsuo T. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis. Atherosclerosis 1993;103:131-8.
42. Skartlien AH, Lyberg-Beckmann S, Holme I, Hjermann I, Prydz H. Effect of alteration in triglyceride levels on factor VII: phospholipid complexes in plasma. Arteriosclerosis 1989;9:798-801.
43. Frishman WH, Ooi WL, Derman MP, Eder HA, Gidez LI, Ben-Zeev D, et al. Serum lipids and lipoproteins in advanced age. Intraindividual changes. Ann Epidemiol 1992;2:43-50.
44. Gylling H, Strandberg T, Tilvis R, Miettinen TA. Regulation of serum cholesterol level in middle-aged and elderly men. Relationship of cholesterol absorption and synthesis to lipoprotein metabolism. Arterioscler Thromb 1994;14:694-700.